bookdialysis partners with Imperial College London Diabetes Centre to offer CKD patients world-class dialysis treatment in Abu Dhabi

• bookdialysis, the world’s leading independent holiday dialysis booking engine, welcomes Abu Dhabi-based Imperial College London Diabetes Centre (ICLDC) to its coveted network of 830 top-tier clinics in more than 50 countries worldwide
• With the new partnership, ICLDC, a member of the M42 group, is now offering travellers with Chronic Kidney Disease (CKD) the possibility to book world-class specialised dialysis treatments online, in just 3 steps, and at no cost for the user
• Τhrough this collaboration, Abu Dhabi becomes the 374th city in the bookdialysis global network

bookdialysis, the world’s leading independent holiday dialysis booking engine, is welcoming ICLDC as the first dialysis facility based in Abu Dhabi, UAE, to be available on its platform. This means that bookdialysis and ICLDC are opening the doors to another favourite world travel destination for international and domestic CKD patients who require dialysis treatment while away from home.

To mark this milestone, bookdialysis was invited by ICLDC to attend Abu Dhabi Global Healthcare Week (ADGHW) 2024, of which M42 is the foundation partner, to participate in a panel discussion entitled ‘Tech-enabled medical tourism’ and a contract signing ceremony, both taking place on Wednesday 15 May.

Evgenia Kafousi, Operations Director for bookdialysis, who attended ADGHW and was a speaker at the panel discussion, said: “We are delighted to partner with M42’s Imperial College London Diabetes Centre to enable travellers in Abu Dhabi to receive world-class kidney care. Travel for dialysis patients can be complex, but with bookdialysis it doesn’t need to be that way. With our user-friendly platform, it is our mission to offer our users the freedom to travel, with the confidence that their treatment continuity is guaranteed while they are away from home, giving them the opportunity to explore the world as anyone else who doesn’t require frequent, life-sustaining treatment. Together with M42 and Imperial College London Diabetes Centre, we are breaking down barriers to patient mobility, empowering individuals in Abu Dhabi and beyond to access world-class kidney care seamlessly”.

bookdialysis was established in 2017 and over the last seven years has emerged as the leading, independent online booking engine for travel dialysis patients worldwide, and a trusted partner of Kidney Patient Associations and the broader CKD community. Boasting a network of over 830 certified dialysis clinics globally and available in nine languages, the platform empowers CKD travellers to travel more, drastically contributing to a better quality of life. With existing partnerships across four continents, including the Gulf region with the UAE, Bahrain and Saudi Arabia, bookdialysis stands by CKD travellers as they decide to embark on transformative journeys while receiving uninterrupted care.

Dr. Mai Al Jaber, Chief Executive Officer of Imperial College London Diabetes Centre, said: “Imperial College London Diabetes Centre's partnership with bookdialysis epitomises our shared commitment to continually improve the quality of life for our patients. Approximately 10 percent of the global population is affected by this disease, amounting to over 800 million people worldwide. By harnessing the transformative power of technology, we are redefining the dialysis travel experience, ensuring that patients who come to the UAE and Abu Dhabi receive unparalleled care and support regardless of where they come from. This collaboration opens up so many opportunities for individuals battling chronic kidney disease, promising enhanced quality of life and limitless options for exploration”.

ICLDC has been at the forefront of diabetes and chronic kidney disease management for more than 18 years. Renowned for its commitment to personalised care, ICLDC's multidisciplinary team of specialists delivers tailored therapy options, resulting in significant improvements in patient health outcomes. The introduction of ICLDC’s low-clearance kidney clinics underscores its unwavering dedication to catering to the diverse needs of patients, ensuring access to life-sustaining treatment for individuals with end-stage renal disease. Now, international travellers visiting the UAE and the region can access ICLDC’s haemodialysis & hemodiafiltration services online, and book their required treatments in real-time, at no cost to the user. Similarly, caregivers at ICLDC can assist dialysis patients in booking holiday treatments through bookdialysis while travelling abroad, empowering them to take control of their own health.

Agapi Manarioti

agapi.manarioti@bookdialysis.com

About bookdialysis

bookdialysis is the world’s leading independent holiday dialysis booking engine. Our user-friendly, ever-evolving and secure digital platform delivers a step-change in how Chronic Kidney Disease (CKD) travellers book their holiday treatments, allowing them to transform travelling into enriching, life-affirming experiences.

Since its establishment in 2017, bookdialysis has become the preferred online booking engine for people on dialysis who wish or need to travel, as well as a trusted partner of renal care providers and the broader CKD community. It is available in nine major languages and offers an easy, quick and simple 3-step booking process, with real-time treatment availability information and no fees attached for the user. In March 2024, bookdialysis launched its own mobile booking application, available on both Android and iOS, as part of its commitment to continuous improvement and innovative solutions. Cooperating closely with kidney patient associations worldwide, bookdialysis also organises group trips for their members every year.

Today, bookdialysis brings together a global network of over 830 certified dialysis clinics in 50 countries across four continents, offering aspiring CKD travellers and their loved ones the freedom to explore new worlds.

For more information, please visit www.bookdialysis.com

About Imperial College London Diabetes Centre

Imperial College London Diabetes Centre (ICLDC), part of M42, is a state-of-the-art outpatient facility that specialises in diabetes treatment, research, training, and public health awareness. In just over a decade, the Centre has gained international renown for its holistic approach to the treatment of diabetes and related complications that enables patients to receive the full spectrum of care they need in one place.

With more than 80 diabetes professionals and endocrinologists under one roof, ICLDC offers best-in-class medical attention from first diagnosis to disease management across 11 specialist practice areas including adult and paediatric endocrinology, treatment of metabolic and electrolyte disorders, pre- and post-bariatric surgery care, heart disease prevention, nutritional advice, diabetes education services, ophthalmology, nephrology, and podiatry.

ICLDC was established in 2006 in Abu Dhabi by Mubadala in partnership with the UK’s Imperial College London to address the growing demand for diabetes care in the UAE. The centre now operates three branches across Abu Dhabi and Al Ain, touching the lives of more than one million people through patient-centric programmes and public health initiatives. In 2007, ICLDC launched Diabetes. Knowledge. Action, now the longest running public health awareness campaign in the country. The initiative promotes an active lifestyle through an ongoing calendar of events for the whole community – Major activations include an annual walkathon that coincides with the World Diabetes Day in November.

ICLDC holds the Joint Commission International (JCI) Clinical Care Program Certification in Outpatient Diabetes Management and JCI Accreditation for Ambulatory Care.

For more information, please visit www.icldc.ae

About M42

M42 is a first-of-its-kind, global tech-enabled health powerhouse committed to the sustainable future of health. The Abu Dhabi-headquartered company is transforming lives through innovative solutions that are solving the world’s most critical health and diagnostic challenges. By harnessing unique medical and data-centric technologies, including genomics and AI, M42 is delivering the highest level of personalised, precise, and preventative health solutions to impactfully disrupt the global health landscape.

M42 has over 20,000 employees and more than 450 facilities in 26 countries. Established in 2022, following the coming together of G42 Healthcare and Mubadala Health, M42 combines leading health technologies with state-of-the-art healthcare facilities to deliver world-class health solutions, services and care.

The M42 group includes Diaverum, Cleveland Clinic Abu Dhabi, Imperial College London Diabetes Centre and Moorfields Eye Hospital Abu Dhabi, among others.